Please login to the form below

Not currently logged in
Email:
Password:

Novo launches online news channel for haemophilia patients

New medical information website aims to be a 'simple, centralised repository'
Novo Nordisk

Novo Nordisk has launched a new website that it hopes will be a simple, centralised repository for haemophilia patients in the US and their carers.

A key feature of RareBleedingDisorders.com will be its news channel, which will cover data from leading medical congresses for patients.

David Cooper, senior director of medical affairs at Novo Nordisk, said: "Novo Nordisk collaborated with medical professionals, people with bleeding disorders and caregivers to create this dynamic resource that helps community members become better informed.

"RareBleedingDisorders.com explores the mechanism of disease, signs and symptoms, and risk factors, as well as the process for appropriate diagnosis and treatment of congenital hemophilia A and B, acquired haemophilia, congenital factor VII deficiency, congenital factor XIII deficiency, Glanzmann's thrombasthenia and other rare bleeding disorders."

The website will feature new disease-state specific information announcements and research updates, links to patient organisations, government bodies and professional organisations, and downloadable information on the condition.

7th October 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics